Velocity’s Family Medicine research site in Portsmouth partners with Churchland Family Medicine, P.C. to conduct clinical trials for a broad range of investigational treatments. Typical studies at this site involve vaccines for infectious illnesses or medications for conditions such as acne, diabetes, high cholesterol, and more. Acquired by Velocity in 2022, the Portsmouth location was founded in 2021 as part of Meridian Clinical Research.
Through the partnership with Churchland, the site is easily accessible to thousands of patients around Portsmouth and Norfolk, including those established with the practice and diverse populations. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Our Portsmouth team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.